In the US medical devices industry, there were 17 private equity deals announced in Q2 2023, worth a total value of $2.3bn, according to GlobalData’s Deals Database. The $2.1bn institutional buy-out (ibo) oneoncology by AmerisourceBergen and TPG Capital was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, private equity deal activity in The US increased by 959% in Q2 2023 compared with the previous quarter’s total of $217.1m and rose by 67% as compared to Q2 2022. Related deal volume increased by 31% in Q2 2023 versus the previous quarter and was 6% higher than in Q2 2022.
The top-ranked financial advisors supporting these private equity deals in The US in Q2 2023 were Piper Sandler Companies; Centerview Partners; Guggenheim Partners with 3, 1, 1 deals respectively.
The top-ranked legal advisorss supporting these private equity deals in The US Q2 2023 were Morgan, Lewis & Bockius; Wilson Sonsini Goodrich & Rosati Professional; Covington & Burling with 2, 2, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.